Key result
Errors in Figure 2, Figure 3, and the Supplement of a previously published article were identified and corrected.
Loading...
Apixaban may lower GI bleed risk vs warfarin in high-risk NVAF; leaves open need for RCTs to guide practice.
Key points are not available for this paper at this time.
A 2021 study studied this question. Errors in Figure 2, Figure 3, and the Supplement of a previously published article were identified and corrected.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: